background


Product Information:

APG-115

Alrizomadlin (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC50 and Ki values of 3.8 nM and 1 nM, respectively. Alrizomadlin blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in a p53-dependent manner.

Cat. No.: EX-A7190    Purity: >98%
Chemical
Chemical structure of APG-115


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
50mg550In-stock
100mg800In-stock
250mg1400In-stock
500mg2050In-stock
1g2800In-stock
2g4900In-stock


SynonymsAlrizomadlin
Synonyms 2AA-115
CAS No.1818393-16-6
Purity>98%
FormulaC34H38Cl2FN3O4
Mol Weight642.588
Appearancesolid powder
SolubilityDMSO >50 mg/mL
Shelf Life>2 years if stored properly
StoragePowder -20℃ 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Angelo Aguilar, et al. 4-((3'R,4'S,5'R)-6″-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2″-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3″-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Do

[2]. A W Tolcher et al, A phase Ib/II study of APG-115 in combination with MK-3475 in patients with unresectable or metastatic melanomas or advanced solid tumors, Ann Oncol. 2019 Feb 1; 30(Supplement_1). pii: mdz027.

[3]. Hanjie Yi ea al, A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma, J Exp Clin Cancer Res. 2018 May 2;37(1):97.

[4]. Chen H, et al. Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells. Oncotarget. 2017 Jun 27;8(26):43008-43022.

CoACoA of APG-115

KEYWORDS: buy APG-115 | APG-115 supplier | purchase | cost | manufacturer | order | distributor | buy 1818393-16-6 | 1818393-16-6 supplier